articleNew England Journal of MedicineJan 16, 2013BRONZE OA

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

Academic Medical Center · University of Amsterdam · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.

Methods

We randomly assigned patients to receive one of three therapies: an initial vancomycin regimen (500 mg orally four times per day for 4 days), followed by bowel lavage and subsequent infusion of a solution of donor feces through a nasoduodenal tube; a standard vancomycin regimen (500 mg orally four times per day for 14 days); or a standard vancomycin regimen with bowel lavage. The primary end point was the resolution of diarrhea associated with C. difficile infection without relapse after 10 weeks.

Citation impact

3,644
total citations
FWCI
198.56
Percentile
100%
References
38
Citations per year

Authors

13

Topics & keywords

Keywords
  • Clostridium difficile
  • Feces
  • Fecal bacteriotherapy
  • Medicine
  • Gastroenterology
  • Microbiology
  • Internal medicine
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding